Mol Biol Rep, 2024, 51(1):130

In vitro and in vivo anti-tumor effect of Trichobakin fused with urokinase-type plasminogen activator ATF-TBK.

Trichobakin (TBK), a member of type I ribosome-inactivating proteins (RIPs), was first successfully cloned from Trichosanthes sp Bac Kan 8-98 in Vietnam. Previous study has shown that TBK acts as a potential protein synthesis inhibitor; however, the inhibition efficiency and specificity of TBK on cancer cells remain to be fully elucidated.

Pham DD, Pham TH, Bui TH, Britikova EV, Britikov VV, Bocharov EV, Usanov SA, Phan VC, Le TBT

Department of structural biology, Laboratory of biomolecular NMR-spectroscopy

: 10.1007/s11033-023-09036-6
Scopus: 2-s2.0-85182686727
: 38236367
IBCH: 11106
Ссылка на статью в журнале: https://link.springer.com/10.1007/s11033-023-09036-6
Нет данных о цитировании
Данные статьи проверены модераторами 2024-01-23

Список научных проектов, где отмечена публикация

  1. QTRU05.01/21–23. . Сommercial.
  2. Х20ЕА-027. . Сommercial.
  3. - (January 6, 2020 — December 31, 2022). Kozlov S.A.. Grant, RFBR.
  4. VINIF.2023.STS.28. . Сommercial.